retrospective study NUMBER patients advanced inoperable gastric cancers referred national cancer center hospital NUMBER NUMBER performed according borrmann classification based x ray findings type NUMBER NUMBER patients type NUMBER NUMBER type NUMBER NUMBER type NUMBER NUMBER patients classified histological type papillary adenocarcinoma NUMBER patients tubular adenocarcinoma NUMBER mucinous carcinoma NUMBER poorly differentiated adenocarcinoma NUMBER signet ring cell carcinoma NUMBER NUMBER site remote metastasis NUMBER patients virchows lymph node NUMBER patients douglas pouch NUMBER liver lung NUMBER NUMBER patients treated telecobalt NUMBER unit linear accelerator using NUMBER mv photon total dose primary lesion NUMBER cgy NUMBER weeks NUMBER cgy weeks complete response cr achieved NUMBER patients NUMBER partial response pr NUMBER NUMBER change nc NUMBER NUMBER response rate based sum cr pr NUMBER NUMBER survival period months NUMBER NUMBER NUMBER respectively patients cr pr nc response advanced gastric cancer chemotherapy national cancer center hospital combined use uft mitomycin c gave highest rate NUMBER local response concerned response rate radiation NUMBER better result chemotherapy NUMBER NUMBER